Patents by Inventor Michael R. Botchan

Michael R. Botchan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicaments for the treatment of papillomavirus diseases
    Patent number: 5925516
    Abstract: Medicaments, and methods of identifying the same, are described that are useful for treating papillomavirus diseases that have the characteristics of preventing, interfering with, or reversing the binding of the appropriate papillomavirus proteins E1 or E2 to a nucleotide sequence homologous to a nucleotide sequence present in the papillomavirus genome, or of the formation of a complex consisting of papillomavirus proteins E1 and E2, or the binding of the complex to the nucleotide sequence.
    Type: Grant
    Filed: April 27, 1995
    Date of Patent: July 20, 1999
    Assignees: Chiron Corporation, University of California
    Inventors: Michael R. Botchan, Robin Clark, Ian J. Mohr, Shaw Sun
  • Methods and compositions for identifying inhibitors of papilloma virus replication
    Patent number: 5620849
    Abstract: Compositions and methods for identifying inhibitors of papilloma virus replication are described consisting of soluble cellular extracts supplemented with purified viral E1 and E2 proteins.
    Type: Grant
    Filed: September 23, 1994
    Date of Patent: April 15, 1997
    Assignees: Cetus Corporation, The Regents of the University of California
    Inventors: Michael R. Botchan, Liu Yang, Rong Li, Ian J. Mohr, Robin Clark
  • Compositions for identification of papillomavirus replication inhibitors
    Patent number: 5464936
    Abstract: Medicaments, and methods of identifying the same, are described that are useful for treating papillomavirus diseases that have the characteristics of preventing, interfering with, or reversing the binding of the appropriate papillomavirus proteins E1 or E2 to a nucleotide sequence homologous to a nucleotide sequence present in the papillomavirus genome, or of the formation of a complex consisting of papillomavirus proteins E1 and E2, or the binding of the complex to the nucleotide sequence.
    Type: Grant
    Filed: December 21, 1990
    Date of Patent: November 7, 1995
    Assignees: Cetus Oncology Corporation, University of California
    Inventors: Michael R. Botchan, Robin Clark, Ian J. Mohr, Shaw Sun